StayWell, a leading health solutions company, today announced that its app — Krames On FHIR® (Fast Healthcare Interoperability Resources) — is now available to Epic users via the App Orchard program.
“We’re excited to have Krames On FHIR on the App Orchard, a versatile program on which Epic invites and encourages innovative add-ons and solutions to support and fulfill niche clinical workflow challenges,” said Nicole Latimer, CEO, StayWell. “Krames On FHIR enables users to deliver award-winning patient education materials at the point of care, saving time for clinicians and creating a more personalized user experience and optimal workflow.”
Using SMART on FHIR® technologies, an open, standards-based health care app platform, Krames On FHIR integrates into the Epic platform, giving providers immediate access within their existing workflows to suggested educational content on thousands of topics included in HealthSheets, lab tests, drug sheets, videos, KidsHealth® instructions, and discharge instructions.
Krames On FHIR also enables Meaningful Use and MACRA reimbursement by offering patient engagement materials tailored specifically to patient age, gender and primary language. Content can also be customized to support the branding and clinical needs of individual hospitals and health systems.
StayWell’s Krames On FHIR features:
Ability to prescribe video content and other assets
Optimized distribution via print, patient portal, and digital options
Automatic updates that ensure accurate and current content
Ability to indicate education favorites by clinician
Capacity to bundle content into folders
Opportunity to customize and brand content
“Krames On FHIR is a valuable tool for hospitals and health systems to deliver customized patient education resources on-demand,” said Latimer. “We are excited to bring this new solution to not only our current valued customers but all who use Epic to improve the health and lives of people around the country and the world.”
Krames On FHIR is now available to Epic customers at apporchard.epic.com. It continues its rollout to users of other major EHR systems through the end of 2017 and into 2018. For additional information, contact firstname.lastname@example.org. To learn more about Krames
On FHIR, visit http://staywell.com/krames-on-fhir-epic/
StayWell is a health solutions company that uses the science of behavior change to help people live happier, healthier lives. StayWell brings decades of experience working across the health care industry to design solutions for improving individual and organizational health outcomes, managing the health of targeted populations, and creating brand engagement for employers and health care organizations. StayWell programs have received numerous top industry honors, including the C. Everett Koop National Health Award and the Web Health Award for health engagement programs. StayWell also has received URAC and NCQA accreditation for several of its programs. StayWell is majority-owned by Healthcare Services & Solutions, LLC, a wholly owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (“Merck”). The company is headquartered in Yardley, PA, and also has a major location in St. Paul, MN. To learn more, visit http://www.staywell.com or connect with StayWell on Twitter, Facebook or LinkedIn.
For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world – including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. For more information, visit http://www.merck.com and connect with us on Twitter, Facebook, YouTube and LinkedIn.
Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA
This news release of The StayWell Company, a subsidiary of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2016 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (http://www.sec.gov).